EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival

D G Sausen, M C Poirier, L M Spiers, E N Smith

Frontiers in Immunology · 21.12.2023 · 14

DOI: 10.3389/fimmu.2023.1289313 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Immunology, online erschienen am 21.12.2023. Verfasst von D G Sausen und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Eastern Virginia Medical School, Norfolk, VA, United States. Hauptthemen laut MEDLINE: Epstein-Barr Virus Infections, Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 259 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Eastern Virginia Medical School.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) is a prevalent oncogenic virus estimated to infect greater than 90% of the world’s population. Following initial infection, it establishes latency in host B cells. EBV has developed a multitude of techniques to avoid detection by the host immune system and establish lifelong infection. T cells, as important contributors to cell-mediated immunity, make an attractive target for these immunoevasive strategies. Indeed, EBV has evolved numerous mechanisms to modulate T cell responses. For example, it can augment expression of programmed cell death ligand-1 (PD-L1), which inhibits T cell function, and downregulates the interferon response, which has a strong impact on T cell regulation. It also modulates interleukin secretion and can influence major histocompatibility complex (MHC) expression and presentation. In addition to facilitating persistent EBV infection, these immunoregulatory mechanisms have significant implications for evasion of the immune response by tumor cells. This review dissects the mechanisms through which EBV avoids detection by host T cells and discusses how these mechanisms play into tumor survival. It concludes with an overview of cancer treatments targeting T cells in the setting of EBV-associated malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epstein-Barr Virus InfectionsNeoplasmsHumansHerpesvirus 4, HumanT-LymphocytesB-Lymphocytes

Stichwörter der Autor:innen

EBVEBV and cancer therapyT cellcancer immune evasionimmune evasionmalignancytumor survival

Autor:innen und Institutionen

  • School of Medicine, Eastern Virginia Medical School, Norfolk, VA, United States.

Förderung

  • Eastern Virginia Medical School

Zitieren

APA

Sausen, D. G., Poirier, M. C., Spiers, L. M., & Smith, E. N. (2023). Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1289313

Vancouver

Sausen DG, Poirier MC, Spiers LM, Smith EN. Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival. Frontiers in Immunology. 2023;14. doi:10.3389/fimmu.2023.1289313

BibTeX
@article{Sausen2023,
  author = {Sausen, D G and Poirier, M C and Spiers, L M and Smith, E N},
  title = {Mechanisms of T cell evasion by Epstein-Barr virus and implications for tumor survival},
  journal = {Frontiers in Immunology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fimmu.2023.1289313}
}
Kostenlos starten →